ArticleFrontiers in medicine2026
Early enteral nutrition and dynamic metabolic-inflammatory trajectories in sepsis: a retrospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early enteral nutrition (EEN) is an important part of sepsis management, but its physiological effects are not fully understood. This study examined whether EEN influences the time course of metabolic and inflammatory biomarkers in patients with sepsis. Methods: We performed a retrospective cohort study of 3,354 adult ICU patients with sepsis admitted to West China Hospital from 2011 to 2025. Group-based trajectory modeling was used to characterize longitudinal patterns of albumin, lactate, and procalcitonin. Associations between EEN and trajectory membership were assessed using multinomial logistic regression. The relationship between trajectory groups and 28-day mortality was further evaluated. Results: Distinct trajectory groups were identified for each biomarker, reflecting heterogeneous nutritional, metabolic, and inflammatory responses. EEN was associated with more favorable albumin trajectories and lower odds of belonging to elevated lactate and procalcitonin patterns. In the multivariate joint trajectory model integrating all three biomarkers, three classes emerged: a stable-low inflammation pattern (67.5%), an intermediate-transient pattern (21.7%), and a high-risk inflammatory surge pattern (10.8%). EEN was independently associated with reduced likelihood of assignment to the intermediate (OR 0.66; 95% CI, 0.52-0.84) and high-risk (OR 0.57; 95% CI, 0.38-0.88) classes. The high-risk trajectory group showed significantly increased 28-day mortality. Conclusion: Initiation of EEN was linked to a higher probability of remaining in low-risk albumin-lactate-PCT trajectories and a lower probability of entering the high-risk inflammatory surge pattern. This pattern-level shift may partly explain the observed reduction in short-term mortality associated with EEN.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.